The Discounted Cash Flow (DCF) valuation of Cytokinetics Inc (CYTK) is (19.91) USD. With the latest stock price at 50.70 USD, the upside of Cytokinetics Inc based on DCF is -139.3%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.8% - 10.4% | 8.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (55.02) - (11.57) | (19.91) |
| Upside | -208.5% - -122.8% | -139.3% |